Description
Bevazza 400mg Injection is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient is Bevacizumab, a recombinant humanized monoclonal antibody. Bevacizumab works by inhibiting vascular endothelial growth factor (VEGF), a protein that stimulates the growth of new blood vessels. By blocking VEGF, Bevazza helps to starve tumors of their blood supply, thereby slowing or stopping their growth. It is commonly used in combination with chemotherapy for the treatment of metastatic colorectal cancer, non-squamous non-small cell lung cancer, and glioblastoma. The dosage and administration of Bevazza 400mg Injection should be strictly determined by a qualified healthcare professional based on the specific cancer type, stage, and individual patient factors. Common side effects may include high blood pressure, proteinuria, nosebleeds, fatigue, and delayed wound healing. It is crucial to inform your doctor about any pre-existing medical conditions, especially cardiovascular issues or recent surgeries. Bevazza 400mg Injection should be stored at room temperature (20°C to 25°C) and protected from light. Do not freeze. Consult your healthcare provider for any concerns regarding its use or potential side effects.
